Dr. Hubbeling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-2428Fax+1 215-349-5923
Education & Training
- Harvard Medical SchoolClass of 2017
Certifications & Licensure
- PA State Medical License 2023 - 2026
- NJ State Medical License 2023 - 2025
Publications & Presentations
PubMed
- Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphoma.Cecilia Jiang, Michele Kim, Xiaoyan Han, Monica Chelius, Travis Hoover
Pediatric Blood & Cancer. 2024-12-01 - Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome.Omar Elghawy, Austin G Yang, Jonathan H Sussman, Colin J Thomas, Jordan S Carter
Journal of the American Academy of Dermatology. 2024-11-16 - Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma.Harper Hubbeling, Doris Leithner, Emily A Silverman, Jessica Flynn, Sean Devlin
Clinical Cancer Research. 2024-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: